- Letter
- Published:
- Dongdong Zhao ORCID: orcid.org/0000-0001-9691-13081na1,
- Ju Li ORCID: orcid.org/0000-0003-0037-41442na1,
- Siwei Li ORCID: orcid.org/0000-0001-6057-29571na1,
- Xiuqing Xin1,3,
- Muzi Hu1,4,
- Marcus A. Price5,
- Susan J. Rosser5,
- Changhao Bi ORCID: orcid.org/0000-0002-1940-85111 &
- …
- Xueli Zhang ORCID: orcid.org/0000-0002-8660-40371
Nature Biotechnology volume39,pages 35–40 (2021)Cite this article
-
21k Accesses
-
262 Citations
-
68 Altmetric
-
Metrics details
Subjects
- Biotechnology
- Molecular biology
A Publisher Correction to this article was published on 29 July 2020
This article has been updated
Abstract
Current base editors (BEs) catalyze only base transitions (C to T and A to G) and cannot produce base transversions. Here we present BEs that cause C-to-A transversions in Escherichia coli and C-to-G transversions in mammalian cells. These glycosylase base editors (GBEs) consist of a Cas9 nickase, a cytidine deaminase and a uracil-DNA glycosylase (Ung). Ung excises the U base created by the deaminase, forming an apurinic/apyrimidinic (AP) site that initiates the DNA repair process. In E. coli, we used activation-induced cytidine deaminase (AID) to construct AID-nCas9-Ung and found that it converts C to A with an average editing specificity of 93.8% ± 4.8% and editing efficiency of 87.2% ± 6.9%. For use in mammalian cells, we replaced AID with rat APOBEC1 (APOBEC-nCas9-Ung). We tested APOBEC-nCas9-Ung at 30 endogenous sites, and we observed C-to-G conversions with a high editing specificity at the sixth position of the protospacer between 29.7% and 92.2% and an editing efficiency between 5.3% and 53.0%. APOBEC-nCas9-Ung supplements the current adenine and cytidine BEs (ABE and CBE, respectively) and could be used to target G/C disease-causing mutations.
This is a preview of subscription content, access via your institution
Access options
Change institution
Buy or subscribe
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 /30days
cancel any time
Learn more
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Learn more
Prices may be subject to local taxes which are calculated during checkout
![Glycosylase base editors enable C-to-A and C-to-G base changes (1) Glycosylase base editors enable C-to-A and C-to-G base changes (1)](https://i0.wp.com/media.springernature.com/m312/springer-static/image/art%3A10.1038%2Fs41587-020-0592-2/MediaObjects/41587_2020_592_Fig1_HTML.png)
![Glycosylase base editors enable C-to-A and C-to-G base changes (2) Glycosylase base editors enable C-to-A and C-to-G base changes (2)](https://i0.wp.com/media.springernature.com/m312/springer-static/image/art%3A10.1038%2Fs41587-020-0592-2/MediaObjects/41587_2020_592_Fig2_HTML.png)
![Glycosylase base editors enable C-to-A and C-to-G base changes (3) Glycosylase base editors enable C-to-A and C-to-G base changes (3)](https://i0.wp.com/media.springernature.com/m312/springer-static/image/art%3A10.1038%2Fs41587-020-0592-2/MediaObjects/41587_2020_592_Fig3_HTML.png)
![Glycosylase base editors enable C-to-A and C-to-G base changes (4) Glycosylase base editors enable C-to-A and C-to-G base changes (4)](https://i0.wp.com/media.springernature.com/m312/springer-static/image/art%3A10.1038%2Fs41587-020-0592-2/MediaObjects/41587_2020_592_Fig4_HTML.png)
Similar content being viewed by others
Linking CRISPR–Cas9 double-strand break profiles to gene editing precision with BreakTag
Article Open access 13 May 2024
Plasmid targeting and destruction by the DdmDE bacterial defence system
Article 13 May 2024
Improving prime editing with an endogenous small RNA-binding protein
Article Open access 03 April 2024
Data availability
There is no restriction on data associated with this study. The raw data for Figs. 1 and 4 and Extended Data Fig. 1 have been submitted with the manuscript. High-throughput sequencing data have been deposited in the NCBI database (accession code SRP265375). Source data are provided with this paper.
Change history
References
Jinek, M. et al. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337, 816–821 (2012).
Fujii, W., Kawasaki, K., Sugiura, K. & Naito, K. Efficient generation of large-scale genome-modified mice using gRNA and Cas9 endonuclease. Nucleic Acids Res. 41, e187 (2013).
Hwang, W. Y. et al. Efficient genome editing in zebrafish using a CRISPR–Cas9 system. Nat. Biotechnol. 31, 227–229 (2013).
Shalem, O. et al. Genome-scale CRISPR–Cas9 knockout screening in human cells. Science 343, 84–87 (2014).
Jiang, Y. et al. Multigene editing in the Escherichia coli genome via the CRISPR–Cas9 system. Appl. Environ. Microbiol. 81, 2506–2514 (2015).
Komor, A. C., Kim, Y. B., Packer, M. S., Zuris, J. A. & Liu, D. R. Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. Nature 533, 420–424 (2016).
Nishida, K. et al. Targeted nucleotide editing using hybrid prokaryotic and vertebrate adaptive immune systems. Science 353, aaf8729 (2016).
Gaudelli, N. M. et al. Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage. Nature 551, 464–471 (2017).
Ma, Y. et al. Targeted AID-mediated mutagenesis (TAM) enables efficient genomic diversification in mammalian cells. Nat. Methods 13, 1029–1035 (2016).
Zhang, Y. et al. Programmable base editing of zebrafish genome using a modified CRISPR–Cas9 system. Nat. Commun. 8, 118 (2017).
Banno, S., Nishida, K., Arazoe, T., Mitsunobu, H. & Kondo, A. Deaminase-mediated multiplex genome editing in Escherichia coli. Nat. Microbiol. 3, 423–429 (2018).
Li, C. et al. Expanded base editing in rice and wheat using a Cas9–adenosine deaminase fusion. Genome Biol. 19, 59 (2018).
Ryu, S.-M. et al. Adenine base editing in mouse embryos and an adult mouse model of duch*enne muscular dystrophy. Nat. Biotechnol. 36, 536–539 (2018).
Shimatani, Z. et al. Inheritance of co-edited genes by CRISPR-based targeted nucleotide substitutions in rice. Plant Physiol. Biochem. 131, 78–83 (2018).
Wang, Y. et al. MACBETH: multiplex automated Corynebacterium glutamicum base editing method. Metab. Eng. 47, 200–210 (2018).
Hess, G. T. et al. Directed evolution using dCas9-targeted somatic hypermutation in mammalian cells. Nat. Methods 13, 1036–1042 (2016).
Komor, A. C., Badran, A. H. & Liu, D. R. CRISPR-based technologies for the manipulation of eukaryotic genomes. Cell 168, 20–36 (2016).
Kim, K. et al. Highly efficient RNA-guided base editing in mouse embryos. Nat. Biotechnol. 35, 435–437 (2017).
Lindahl, T. An N-glycosidase from Escherichia coli that releases free uracil from DNA containing deaminated cytosine residues. Proc. Natl Acad. Sci. USA 71, 3649–3653 (1974).
Zheng, K. et al. Highly efficient base editing in bacteria using a Cas9–cytidine deaminase fusion. Commun. Biol. 1, 32 (2018).
Ran, F. A. et al. In vivo genome editing using Staphylococcus aureus Cas9. Nature 520, 186–191 (2015).
Kleinstiver, B. P. et al. Engineered CRISPR–Cas9 nucleases with altered PAM specificities. Nature 523, 481–485 (2015).
Hu, J. H. et al. Evolved Cas9 variants with broad PAM compatibility and high DNA specificity. Nature 556, 57–63 (2018).
Anzalone, A. V. et al. Search-and-replace genome editing without double-strand breaks or donor DNA. Nature 576, 149–157 (2019).
Engler, C., Kandzia, R. & Marillonnet, S. A one pot, one step, precision cloning method with high- throughput capability. PLoS ONE 3, e3647 (2008).
Hillson, N. J., Rosengarten, R. D. & Keasling, J. D. j5 DNA assembly design automation software. ACS Synth. Biol. 1, 14–21 (2011).
Zhao, J. et al. Engineering central metabolic modules of Escherichia coli for improving β-carotene production. Metab. Eng. 17, 42–50 (2013).
Qi, L. S. et al. Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression. Cell 152, 1173–1183 (2013).
Feng, X., Zhao, D., Zhang, X., Ding, X. & Bi, C. CRISPR/Cas9 assisted multiplex genome editing technique in Escherichia coli. Biotechnol. J. 13, e1700604 (2018).
Bae, S., Park, J. & Kim, J. S. Cas-OFFinder: a fast and versatile algorithm that searches for potential off-target sites of Cas9 RNA-guided endonucleases. Bioinformatics 30, 1473–1475 (2014).
Acknowledgements
This research was financially supported by the National Key Research and Development Program of China (2019YFA0904900), the Key Research Program of the Chinese Academy of Science (KFZD-SW-215), the National Natural Science Foundation of China (31861143019), a Newton Fund PhD placement program grant (ID 352639434) under the UK–China Joint Research and Innovation Partnership Fund and the Tianjin Synthetic Biotechnology Innovation Capacity Improvement Project (TSBICIP-PTJS-003). We gratefully thank F. Gu (Wenzhou Medical University) for providing the plasmid pAPOBEC-nCas9-UGI and Y. Li (Tianjin Institute of Industrial Biotechnology) for assisting with the data analysis.
Author information
Author notes
These authors contributed equally: Dongdong Zhao, Ju Li, Siwei Li.
Authors and Affiliations
Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, Tianjin, China
Dongdong Zhao,Siwei Li,Xiuqing Xin,Muzi Hu,Changhao Bi&Xueli Zhang
College of Life Science, Tianjin Normal University, Tianjin, China
Ju Li
College of Biotechnology, Tianjin University of Science and Technology, Tianjin, China
Xiuqing Xin
School of Biological Engineering, Dalian Polytechnic University, Dalian, China
Muzi Hu
Centre for Synthetic and Systems Biology and UK Centre for Mammalian Synthetic Biology, School of Biological Sciences, University of Edinburgh, Edinburgh, UK
Marcus A. Price&Susan J. Rosser
Authors
- Dongdong Zhao
View author publications
You can also search for this author in PubMedGoogle Scholar
- Ju Li
View author publications
You can also search for this author in PubMedGoogle Scholar
- Siwei Li
View author publications
You can also search for this author in PubMedGoogle Scholar
- Xiuqing Xin
View author publications
You can also search for this author in PubMedGoogle Scholar
- Muzi Hu
View author publications
You can also search for this author in PubMedGoogle Scholar
- Marcus A. Price
View author publications
You can also search for this author in PubMedGoogle Scholar
- Susan J. Rosser
View author publications
You can also search for this author in PubMedGoogle Scholar
- Changhao Bi
View author publications
You can also search for this author in PubMedGoogle Scholar
- Xueli Zhang
View author publications
You can also search for this author in PubMedGoogle Scholar
Contributions
X.Z., C.B. and J.L. designed the research, analyzed data and wrote the manuscript. D.Z. designed the research, performed experiments, analyzed data and wrote the manuscript. S.L. performed experiments and analyzed data. M.A.P. performed experiments and wrote the manuscript. S.J.R. wrote the manuscript. X.X. and M.H. performed experiments.
Corresponding authors
Correspondence to Changhao Bi or Xueli Zhang.
Ethics declarations
Competing interests
A provisional patent has been submitted in part entailing the reported approach.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Extended data
Extended Data Fig. 1 Sequencing data results following CBE.
a, Results obtained following treatment with nCas9-AID in E. coli MG1655 Δung. b, Results obtained following treatment with dCas9-AID in wild type E. coli MG1655. For all plots, dots represent individual biological replicates, bars represent mean values, and error bars represent the s.d. of three independent biological replicates.
Source data
Supplementary information
Supplementary Information
Supplementary Tables 1, 2, 4 and 7; Supplementary Figs. 1 and 2; and DNA sequences for vector components.
Supplementary Table 3
Mutations of APOBEC-nCas9-UGI and APOBEC-nCas9-Ung at RP11-177B4-3, PSMB2-1 and EMX1-site5 using mismatched sgRNAs.
Supplementary Table 5
The main primers used for this work.
Supplementary Table 6
The main plasmids used for this work.
Source data
Source Data Fig. 1
Statistical source data.
Source Data Fig. 4
Statistical source data.
Source Data Extended Data Fig. 1
Statistical source data.
Rights and permissions
About this article
Cite this article
Zhao, D., Li, J., Li, S. et al. Glycosylase base editors enable C-to-A and C-to-G base changes. Nat Biotechnol 39, 35–40 (2021). https://doi.org/10.1038/s41587-020-0592-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41587-020-0592-2
This article is cited by
-
Targeted C•G-to-T•A base editing with TALE-cytosine deaminases in plants
- Dingbo Zhang
- Vanessa Pries
- Jens Boch
BMC Biology (2024)
-
Adenine transversion editors enable precise, efficient A•T-to-C•G base editing in mammalian cells and embryos
- Liang Chen
- Mengjia Hong
- Dali Li
Nature Biotechnology (2024)
-
CRISPR/Cas9-mediated base editors and their prospects for mitochondrial genome engineering
- Shahin Eghbalsaied
- Clancy Lawler
- Stephen Frankenberg
Gene Therapy (2024)
-
Recent advances in CRISPR-based functional genomics for the study of disease-associated genetic variants
- Heon Seok Kim
- Jiyeon Kweon
- Yongsub Kim
Experimental & Molecular Medicine (2024)
-
Precise genome-editing in human diseases: mechanisms, strategies and applications
- Yanjiang Zheng
- Yifei Li
- Yimin Hua
Signal Transduction and Targeted Therapy (2024)